345 EAST MAIN STREET, WARSAW, IN
Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Announces Second Quarter 2026 Financial Results
Files Current Report on Form 8-K to Recast Financial Information
Zimmer Biomet Holdings Enters $1.5 Billion Revolving Credit Agreement
Zimmer Biomet Holdings Elects Directors and Ratifies Auditor for 2026
Increases Share Repurchase Expectations — Up to $1 Billion by Year End
Announces First Quarter 2026 Financial Results
Announces Chief Financial Officer Transition
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Certificate
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Free Writing Prospectus